ALTRINSIC GLOBAL ADVISORS LLC - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALTRINSIC GLOBAL ADVISORS LLC ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$5,559,000
+38.0%
371,100
+12.1%
0.16%
+38.9%
Q1 2016$4,029,000
-23.5%
331,1000.0%0.11%
-17.5%
Q4 2015$5,268,000
+3.8%
331,1000.0%0.14%
+16.1%
Q3 2015$5,076,000
-25.7%
331,100
+17.8%
0.12%
-15.7%
Q2 2015$6,834,000
+24.2%
281,100
+18.8%
0.14%
+16.7%
Q1 2015$5,501,000236,6000.12%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders